China Resources Double-Crane Pharmaceutical Co.,Ltd.

SHSE:600062 주식 보고서

시가총액: CN¥21.4b

China Resources Double-Crane PharmaceuticalLtd 관리

관리 기준 확인 0/4

China Resources Double-Crane PharmaceuticalLtd CEO는 Wenchao Lu, Jul2024 에 임명되었습니다 의 임기는 1년 미만입니다. 는 CN¥ 5.15M 가치에 해당하는 회사 주식의 0.024% 직접 소유합니다. 5.15M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 2.9 년입니다.

주요 정보

Wenchao Lu

최고 경영자

CN¥2.3m

총 보상

CEO 급여 비율n/a
CEO 임기less than a year
CEO 소유권0.02%
경영진 평균 재임 기간1.8yrs
이사회 평균 재임 기간2.9yrs

최근 관리 업데이트

Recent updates

The China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) First-Quarter Results Are Out And Analysts Have Published New Forecasts

Oct 29
The China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) First-Quarter Results Are Out And Analysts Have Published New Forecasts

China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Low P/E No Reason For Excitement

Oct 21
China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Low P/E No Reason For Excitement

An Intrinsic Calculation For China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Suggests It's 49% Undervalued

Sep 30
An Intrinsic Calculation For China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Suggests It's 49% Undervalued

We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

Jul 16
We Think China Resources Double-Crane PharmaceuticalLtd (SHSE:600062) Can Manage Its Debt With Ease

China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 24
China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHSE:600062) Just Reported And Analysts Have Been Lifting Their Price Targets

Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

Mar 02
Investors Don't See Light At End Of China Resources Double-Crane Pharmaceutical Co.,Ltd.'s (SHSE:600062) Tunnel

CEO

Wenchao Lu (47 yo)

less than a year

테뉴어

CN¥2,319,500

보상

Mr. Wenchao Lu is Chairman of the board of China Resources Double-Crane Pharmaceutical Co. Ltd. from September 21, 2023 and serves as its Acting President since July 2024. Mr. Lu was President of China Res...


리더십 팀

이름위치테뉴어보상소유권
Wenchao Lu
Chairman of the Board & Acting Presidentless than a yearCN¥2.32m0.024%
CN¥ 5.1m
Hekai Tan
VP & Company Secretaryno dataCN¥1.11m0.014%
CN¥ 3.0m
Ziqin Liu
Vice President3.8yrsCN¥1.60m0.018%
CN¥ 3.8m
Chao Man
Vice President3.8yrsCN¥1.80m0.025%
CN¥ 5.4m
Donghan Yao
Vice President1.8yrsCN¥923.00k데이터 없음
Ju Liu
Chief Financial Officerless than a year데이터 없음데이터 없음

1.8yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 관리: 600062 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Wenchao Lu
Chairman of the Board & Acting President2.3yrsCN¥2.32m0.024%
CN¥ 5.1m
Xiangming Li
Director3.1yrs데이터 없음데이터 없음
Ning Liu
Independent Director3.3yrsCN¥150.00k데이터 없음
Maozhu Sun
Independent Director3.3yrsCN¥150.00k데이터 없음
Na Tang
Chairman of the Supervisory Board3.3yrs데이터 없음데이터 없음
Lili Yan
Employee Supervisor8.2yrs데이터 없음데이터 없음
Xiaosong Bai
Director2.7yrs데이터 없음데이터 없음
Wei Sang
Employee Supervisor3.3yrs데이터 없음데이터 없음
Shutian Yu
Director1.9yrs데이터 없음데이터 없음
Hui Xu
Director1.1yrs데이터 없음데이터 없음
Guolong Lin
Director1.1yrs데이터 없음데이터 없음
Zhen Chen
Independent Directorless than a year데이터 없음데이터 없음

2.9yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 이사회: 600062 의 이사회경험(평균 재직 기간 2.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.